rs78317153

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000512.5(GALNS):​c.758+22C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.055 in 1,613,532 control chromosomes in the GnomAD database, including 2,915 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.050 ( 252 hom., cov: 33)
Exomes 𝑓: 0.056 ( 2663 hom. )

Consequence

GALNS
NM_000512.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.66

Publications

3 publications found
Variant links:
Genes affected
GALNS (HGNC:4122): (galactosamine (N-acetyl)-6-sulfatase) This gene encodes N-acetylgalactosamine-6-sulfatase which is a lysosomal exohydrolase required for the degradation of the glycosaminoglycans, keratan sulfate, and chondroitin 6-sulfate. Sequence alterations including point, missense and nonsense mutations, as well as those that affect splicing, result in a deficiency of this enzyme. Deficiencies of this enzyme lead to Morquio A syndrome, a lysosomal storage disorder. [provided by RefSeq, Jul 2008]
GALNS Gene-Disease associations (from GenCC):
  • mucopolysaccharidosis type 4A
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 16-88835703-G-A is Benign according to our data. Variant chr16-88835703-G-A is described in ClinVar as Benign. ClinVar VariationId is 256336.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0735 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000512.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GALNS
NM_000512.5
MANE Select
c.758+22C>T
intron
N/ANP_000503.1
GALNS
NM_001323544.2
c.776+22C>T
intron
N/ANP_001310473.1
GALNS
NM_001323543.2
c.203+22C>T
intron
N/ANP_001310472.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GALNS
ENST00000268695.10
TSL:1 MANE Select
c.758+22C>T
intron
N/AENSP00000268695.5
GALNS
ENST00000562593.5
TSL:1
n.4167+22C>T
intron
N/A
GALNS
ENST00000562931.5
TSL:5
n.346+22C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0501
AC:
7623
AN:
152162
Hom.:
251
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0364
Gnomad AMI
AF:
0.0253
Gnomad AMR
AF:
0.0496
Gnomad ASJ
AF:
0.120
Gnomad EAS
AF:
0.00135
Gnomad SAS
AF:
0.0800
Gnomad FIN
AF:
0.0227
Gnomad MID
AF:
0.168
Gnomad NFE
AF:
0.0604
Gnomad OTH
AF:
0.0584
GnomAD2 exomes
AF:
0.0519
AC:
13031
AN:
251006
AF XY:
0.0549
show subpopulations
Gnomad AFR exome
AF:
0.0377
Gnomad AMR exome
AF:
0.0340
Gnomad ASJ exome
AF:
0.123
Gnomad EAS exome
AF:
0.000489
Gnomad FIN exome
AF:
0.0227
Gnomad NFE exome
AF:
0.0598
Gnomad OTH exome
AF:
0.0604
GnomAD4 exome
AF:
0.0555
AC:
81165
AN:
1461252
Hom.:
2663
Cov.:
32
AF XY:
0.0572
AC XY:
41576
AN XY:
726930
show subpopulations
African (AFR)
AF:
0.0386
AC:
1292
AN:
33472
American (AMR)
AF:
0.0389
AC:
1739
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.126
AC:
3281
AN:
26134
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39694
South Asian (SAS)
AF:
0.0810
AC:
6980
AN:
86226
European-Finnish (FIN)
AF:
0.0230
AC:
1220
AN:
53016
Middle Eastern (MID)
AF:
0.108
AC:
625
AN:
5768
European-Non Finnish (NFE)
AF:
0.0563
AC:
62641
AN:
1111842
Other (OTH)
AF:
0.0560
AC:
3382
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
4269
8539
12808
17078
21347
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2314
4628
6942
9256
11570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0501
AC:
7624
AN:
152280
Hom.:
252
Cov.:
33
AF XY:
0.0492
AC XY:
3662
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.0364
AC:
1515
AN:
41564
American (AMR)
AF:
0.0495
AC:
757
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.120
AC:
415
AN:
3472
East Asian (EAS)
AF:
0.00135
AC:
7
AN:
5172
South Asian (SAS)
AF:
0.0800
AC:
386
AN:
4822
European-Finnish (FIN)
AF:
0.0227
AC:
241
AN:
10614
Middle Eastern (MID)
AF:
0.170
AC:
50
AN:
294
European-Non Finnish (NFE)
AF:
0.0604
AC:
4108
AN:
68016
Other (OTH)
AF:
0.0578
AC:
122
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
379
757
1136
1514
1893
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
98
196
294
392
490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0597
Hom.:
126
Bravo
AF:
0.0504
Asia WGS
AF:
0.0310
AC:
107
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jun 18, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Apr 24, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mucopolysaccharidosis, MPS-IV-A Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.28
DANN
Benign
0.58
PhyloP100
-1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs78317153; hg19: chr16-88902111; COSMIC: COSV107276889; COSMIC: COSV107276889; API